IRVINE, Calif., Dec. 5, 2019 /PRNewswire-PRWeb/ — StudyKIK, a patient recruitment and technology company that builds digital patient communities and enrollment technology solutions for clinical trials, has launched an e-consent solution with seamless integration...
RYE BROOK, N.Y., Dec. 6, 2019 /PRNewswire/ — The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and...
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently lack an approved drug therapy, but this may soon change. A large Phase III clinical trial designed in collaboration with...
BOSTON, Dec. 5, 2019 /PRNewswire/ — EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that the efficacy and safety data from the REVERSE-SD clinical study were presented at the Clinical Trials in Alzheimer’s Disease...
Enrollment in the Phase 2 clinical trial of setanaxib (GKT831), an oral investigational treatment for idiopathic pulmonary fibrosis (IPF), will start in the coming weeks, Genkyotex announced in a progress report. Following approval by the U.S. Food and Drug...
Email
Text